Oral cephalexin for acne vulgaris: clinical experience with 93 patients

Pediatric Dermatology
Julie A FennerNikki A Levin

Abstract

For patients who fail traditional acne therapy or experience side effects, other treatments are needed. Cephalexin has been noted to be efficacious in some instances. This study aimed to assess the therapeutic efficacy of cephalexin for acne. A retrospective chart review of 93 acne patients treated with cephalexin was performed. Data collection included patient demographics, other acne therapies, clinical response, and side effects. Of the 98 courses of cephalexin, 4% of patients cleared, 45% were much improved, 29% were somewhat improved, 16% experienced no change, and 6% worsened at first follow-up visit. The median treatment length was 6 months. Eighty-four percent of patients had previously used a systemic antibiotic(s) for acne. Seven percent experienced adverse effects. This is a small retrospective analysis without a comparison group and is limited by the number of patients and nonstandardized treatment lengths and charting procedures. Cephalexin is a promising alternative treatment for acne, with 78% of patients exhibiting at least some clinical improvement.

References

Jan 1, 1978·The Journal of Investigative Dermatology·N B EsterlyL E Flanagan
Jun 1, 1986·Journal of the American Academy of Dermatology·R D Sheeler
Jul 1, 1994·Drugs·N L Sykes, G F Webster
Oct 1, 1994·Der Gynäkologe·U OertelG Goerz
May 1, 1997·Journal of the American Academy of Dermatology·S E HelmsI Krishnarao
Apr 29, 1998·Dermatology : International Journal for Clinical and Investigative Dermatology·H Akamatsu, T Horio
Oct 8, 1998·The Medical Journal of Australia·A J Cooper
Dec 25, 2002·Trends in Pharmacological Sciences·Dong Soon Im
Mar 26, 2003·The British Journal of Dermatology·J I RossJ H Cove
Jul 23, 2003·Current Medicinal Chemistry·Grigory VeinbergEdmunds Lukevics
Feb 19, 2004·JAMA : the Journal of the American Medical Association·Christine M VelicerStephen H Taplin
Sep 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Tom Burns, Stefan Priebe
Jul 5, 2005·Pediatrics in Review·Daniel P Krowchuk

❮ Previous
Next ❯

Citations

May 10, 2013·Drugs·Y L Kong, H L Tey
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Jonette Keri, Michael Shiman
Jan 16, 2014·American Journal of Clinical Dermatology·Lindsey Yeo, Anthony D Ormerod
Feb 22, 2016·Journal of the American Academy of Dermatology·Andrea L ZaengleinKevin M Boyer
Oct 14, 2011·Seminars in Cutaneous Medicine and Surgery·Albert C YanAnthony J Mancini
Jun 27, 2009·Experimental Dermatology·Ichiro KurokawaChristos C Zouboulis
Feb 21, 2014·Dermatologic Therapy·Shehla Admani, Victoria R Barrio
May 18, 2012·Dermatologic Therapy·Rana Majd MaysSirunya Silapunt
Jun 13, 2014·International Journal of Health Services : Planning, Administration, Evaluation·Werner SoorsJean-Pierre Unger
Jan 11, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S K Bechstein, F Ochsendorf
Sep 13, 2020·American Journal of Clinical Dermatology·Dillon J Patel, Neal Bhatia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Journal of the American Academy of Dermatology
A S ColtonA P Kowalczyk
Journal of the European Academy of Dermatology and Venereology : JEADV
Y TüzünA Kotogyan
Archives of Dermatology
N B EsterlyJ C Garancis
© 2022 Meta ULC. All rights reserved